Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Philip B. Donenberg currently holds 44,322 shares of BIOSANTE PHARMACEUTICALS INC (BPAX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Philip B. Donenberg has been a net buyer of BPAX stock. They have purchased $16.9K and sold $0 worth of shares.
Philip B. Donenberg's most recent insider trade was on Aug 8, 2011, when they purchased 1,000 shares at $2.23 per share.
Philip B. Donenberg serves as Executive at BIOSANTE PHARMACEUTICALS INC (BPAX). They have executed 12 insider transactions totaling $16.9K over their tenure at the company.
Philip B. Donenberg holds the position of Executive at BIOSANTE PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Philip B. Donenberg has shown a buying trading pattern, with $16.9K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Philip B. Donenberg was on Mar 27, 2006, when they sold $120.0K worth of BPA shares. This transaction involved 52,188 shares at $2.30 per share.
Philip B. Donenberg currently owns 44,322 shares of BIOSANTE PHARMACEUTICALS INC (BPAX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Philip B. Donenberg's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Philip B. Donenberg has 12 Form 4 filings on record as an insider at BIOSANTE PHARMACEUTICALS INC.
Set alerts for Philip B. Donenberg and 40,000+ other insiders.